Physician profile
Michael I Horowitz
NPI 1447498415
$596.22
in general payments reported to CMS, 2019-2025
15 companies · $57.91 in 2025
The $57.91 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $55.51 · 2021: $82.79 · 2022: $140 · 2023: $29.14 · 2024: $19.96 · 2025: $57.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $108.41 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $89.60 | 2020-2023 | Xiaflex |
| Boston Scientific Corporation | $74.58 | 2019-2022 | |
| Abbvie INC. | $58.68 | 2022 | |
| Integra Lifesciences Corporation | $48.93 | 2019 | |
| Stryker Corporation | $34.27 | 2023-2024 | Conextions Tr Tendon Repair System-Implant Mechanism, Vitoss |
| Amgen INC. | $33.04 | 2025 | Krystexxa |
| Arteriocyte Medical Systems, INC. | $27.74 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.87 | 2025 | |
| Fidia Pharma USA INC. | $21.75 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.46 | 2022 | |
| Redhill Biopharma INC. | $15.62 | 2020 | |
| Carestream Health, INC. | $14.89 | 2020 | |
| Axogen | $14.68 | 2021 | |
| Theragen, INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Horowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.